Shares of Alfacell Corportion (ACEL) Plunge on Preliminary Phase IIIb Trial Results for ONCONASE®
Shares of Alfacell Corporation (NASDAQ: ACEL), a biopharmaceutical company engaged primarily in the research and development of novel ribonuclease (RNase)…